New Delhi: The Chinese vaccine developed by Synovac Biotech has now been shown to have the potential to fight the coronavirus after the Phase 4 and modern vaccines. The vaccine has been shown to be effective in volunteers in clinical trials in Brazil. The vaccine has now been included in the race after the company claimed that the Fischer and Modern vaccine was about 90 percent successful. . But in his view, Sinovac is better. However, Synovac does not have the ability to create as many antibodies. Notably, there have been some flaws in the vaccine of the American pharmaceutical company ‘Fizer’, which has claimed success in the preparation of the Covid vaccine. Volunteers who were vaccinated during the test showed headaches, weight gain, muscle spasms, and fevers. It has also been reported that the biotechnology company Madarna is also moving towards a successful vaccine.
